跳转至内容
Merck
CN
  • Generation of human iPSC-derived neurofibromaspheres for in vitro and in vivo uses.

Generation of human iPSC-derived neurofibromaspheres for in vitro and in vivo uses.

STAR protocols (2023-03-29)
Helena Mazuelas, Itziar Uriarte-Arrazola, Juana Fernández-Rodríguez, Miriam Magallón-Lorenz, Alberto Villanueva, Conxi Lázaro, Bernat Gel, Eduard Serra, Meritxell Carrió
摘要

Neurofibromas are benign peripheral nervous system tumors associated with neurofibromatosis type 1, which originate from NF1(-/-) Schwann cell precursors. We describe a protocol to generate neurofibromaspheres by differentiating NF1(-/-) Schwann cells from induced pluripotent stem cells and combining them with neurofibroma primary fibroblasts. We also describe the development of neurofibroma-like tumors when neurofibromaspheres are engrafted in the sciatic nerve of nude mice. This model constitutes a versatile platform for drug screening and the study of neurofibroma biology. For complete details on the use and execution of this protocol, please refer to Mazuelas et al. (2022).1.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
毛喉素, from Coleus forskohlii, ≥98% (HPLC), powder
Sigma-Aldrich
脱铁转铁蛋白 人, powder, BioReagent, suitable for cell culture, ≥98% (agarose gel electrophoresis)
Sigma-Aldrich
抗HNK-1/N-CAM (CD57) 小鼠单克隆抗体 小鼠抗, clone VC1.1, purified from hybridoma cell culture